Acne News

• Impact of Pregnancy on Rosacea Unpredictable, Study Suggests Nearly half of study participants reported that their rosacea worsened when they were pregnant.
  Medscape Medical News, January 05, 2024
• Reducing CVD Morbidity and Mortality in Psoriasis and PsA Only a minority of patients with psoriatic disease know about their increased risks.
  MDedge News, December 20, 2023
  1
• Acne in Primary Care: The Best of Times? The repackaging of old medications into new formulations that are easier on the skin, and the availability of combination drug creams, should improve acne care.
  Medscape Medical News, December 13, 2023
  2
• Acne Stigma Persists Across Social and Professional Settings Individuals with severe acne were considered less attractive, less worthy of friendship, and less likely to be hired for a job compared with those who did not have acne.
  MDedge News, December 12, 2023
• Bimekizumab Promising for Palmoplantar Pustular Psoriasis PPP is a type of pustular psoriasis that remains a treatment challenge, and available treatments for palmoplantar plaque psoriasis with pustules also "remain unsatisfactory."
  MDedge News, December 12, 2023
  1
• Patients With hEDS Report Skin Laxity, Scarring Follicular occlusion, mast cell disease, and eczema were common presentations among patients with hypermobile Ehlers-Danlos syndrome.
  MDedge News, December 07, 2023
  2
• How Can Dermatologists Improve Cancer Care? Dermatologists play a key role on interdisciplinary treatment teams.
  Medscape Medical News, December 06, 2023
• Alert FDA Mandates Changes to iPLEDGE Program for Isotretinoin Isotretinoin manufacturers have 6 months to make five changes to existing iPLEDGE Risk Evaluation and Mitigation Strategy (REMS) requirements for isotretinoin.
  MDedge News, December 06, 2023
  1
• MSWS 2023 What's New in Acne Treatment? Advances in acne care include the use of light-based devices.
  Medscape Medical News, December 04, 2023
• Meta-Analysis: Suicide Risk Not Increased With Isotretinoin In fact, those treated with the drug for severe acne may have a lower risk for suicide attempts 2-4 years after treatment, according to the study authors.
  MDedge News, December 01, 2023
• EADV 2023 At 52 Weeks, Hair Growth Still Climbing on Deuruxolitinib With response curves still climbing at follow-up to date, the results are 'truly, truly remarkable.'
  MDedge News, November 28, 2023
  7
• Questionnaire Measures Patient Satisfaction With Acne Tx A dermatology-specific questionnaire assessed three aspects of treatment in patients with acne.
  Medscape Medical News, November 22, 2023
• EADV 2023 Vitiligo: 'Impressive' Results for Povorcitinib, Baricitinib Substantial facial and total body repigmentation in patients with nonsegmental vitiligo was achieved in separate trials of povorcitinib and baricitinib plus phototherapy.
  Medscape Medical News, November 08, 2023
• EADV 2023 Topical Ivermectin Study Sheds Light on Dysbiosis in Rosacea Study findings show that ivermectin reduces the density of Demodex folliculorum in rosacea lesions, but the skin microbiome takes time to recover.
  Medscape Medical News, November 03, 2023
  3
• Multicenter HS Study Expanding to More Clinical Sites Among the objectives of the study, which aims to enroll 8000 patients with HS, is to collect biospecimens from patients for translational studies.
  Medscape Medical News, October 27, 2023
• Acne: Study Evaluates the Evidence for Nutraceuticals Despite the many acne treatments available, 'patients may be interested in natural and complementary therapies as either an adjunctive or an alternative to prescription medications,' the authors said.
  MDedge News, October 27, 2023
• Alert FDA Approves Triple Combination Topical Treatment for Acne The product combines an antibiotic, a retinoid, and an antibacterial in a gel formulation.
  MDedge News, October 25, 2023
• Review Estimates Acne Risk With JAK Inhibitor Therapy A systematic review and meta-analysis with more than 10,000 individuals showed a significant increase in acne associated with JAK inhibitors.
  Medscape Medical News, October 19, 2023
• Alert FDA Approves Bimekizumab for Plaque Psoriasis in Adults Bimekizumab is the first IL-17A and IL-17F inhibitor approved by the FDA for adults with psoriasis.
  Medscape Medical News, October 18, 2023
• Once-Weekly Topical Therapy Shows Promise for Acne Researchers say the novel once-weekly application could improve patient adherence.
  Medscape Medical News, October 13, 2023
• Novel Triple Threat Approach to Acne Beats Placebo A topical therapy that combines three acne medications applied once a day showed efficacy superior to a vehicle in two phase 3 studies of children and adults with moderate to severe acne.
  Medscape Medical News, October 12, 2023
  4
• Illicit Steroids: If MDs Don't Ask, Patients Won't Tell If clinicians are uncomfortable addressing use of anabolic-androgen steroids, patients will continue to look to each other and the internet to fill the void.
  Medscape Medical News, October 10, 2023
  12
• Spironolactone Effective Treatment for Women With HS, Study The anti-androgenic agent is used to treat HS in women, but there is a paucity of data on its efficacy and whether certain patient characteristics influence response.
  MDedge News, October 04, 2023
• HS Experts Reach Consensus on Treatment Outcome Measures The goal of the Hidradenitis Suppurativa Core Outcomes Set International Collaboration (HiSTORIC) group was to develop a set of core outcomes for HS to be used in research and clinical practice.
  Medscape Medical News, September 27, 2023
• Alert European Commission Approves Ritlecitinib for Severe AA This makes ritlecitinib the first medicine authorized by the EC to treat individuals with severe alopecia areata as young as 12 years of age.
  MDedge News, September 19, 2023
  1
• When Treating Scars, ‘Rehabilitation’ is the Goal "When you treat a scar, you treat the features of the scar that make it stand out."
  MDedge News, September 18, 2023
• Expert Reviews Use of Noninvasive Fat Removal Procedures CoolSculpting freezes excess fat to remove it from stubborn areas via panniculitis. It accounts for about 72% of the noninvasive fat removal treatments performed in the US, according to an expert.
  MDedge News, September 07, 2023
  5
• Analysis Reveals Recent Acne Prescribing Trends The study found that for women with acne, prescriptions for spironolactone increased about three- to fourfold during the study period among all clinician types.
  MDedge News, August 18, 2023
  1